The global pharmaceutical industry stood at USD1,423.54 billion in 2021.
To enhance the processing, appearance, and swallowability of oral medication products with an instant release profile, Evonik launched EUDRAGIT ready-to-use powder premix.
Over the past ten years, there have been more new medications licensed each year. Between 2010 and 2019 (with a peak of 59 in 2018), the Food and Drug Administration (FDA) approved 38 new medications on average, which is 60% more than it did on an annual average over the preceding ten years. The FDA has approved a large number of specialty medications for the treatment of chronic disorders.
During the forecast period, the growth of the global tablet coating market is expected to be constrained by strict regulations governing the approval of pharmaceuticals and the high cost of the encapsulating procedure.
Growing Pharmaceutical Industry
In OECD countries, prescription pharmaceuticals accounted for 79% of pharmaceutical spending in 2019, with OTC products making up the remaining 21%. Each year, the American pharmaceutical industry develops a large number of novel drugs with considerable medical benefits. The price of many of those pharmaceuticals increases healthcare costs for both the federal government and the private sector. Approximately one-quarter of pharmaceutical company’s sales, or approximately twice as much as they did in 2000, were spent on R&D in 2019. Over 238 billion dollars were spent on research and development by the pharmaceutical industry globally in 2021.
A significant amount of pharmaceutical companies R&D is being contracted out to clinical research organizations, also known as contract research organizations, with the primary objective of reducing costs. Another significant development is the use of big data in clinical research. Thus, a prediction model that incorporates clinical and molecular data can be developed to provide drugs that are both safer and more effective. Real-time or real-world evidence (RWE) is gaining more and more traction. This involves collaborating with digital companies and using data gathered from many sources, including social media. As a result, the pharmaceutical industry will continue to grow throughout the duration of the projected years, driving growth in the global tablet coating market.
Rise in Chronic Diseases
Growing prevalence of chronic diseases such as cancer, diabetes, gastrointestinal disorders, renal problems, respiratory problems, among others has significantly increased the demand for different types of tablets used for treating and managing them, thereby driving the growth of global tablet coating market in the coming years. Chronic conditions like diabetes, cancer, and heart disease are the primary causes of death and disability in the United States. They are also the key reasons for the nation's 4.1 trillion USD in annual health care expenditures.
Market Segmentation
Global tablet coating market is segmented by
Market Players
Holding major shares of the global tablet coating market, major competitors are Air Liquide S.A., Sensient Technologies Corporation Ltd., Merck KGaA, Kerry Group PLC, DuPont De Numeours Inc., Aquadry Pharma Pvt. Ltd., BASF SE, Biogrund GmbH, Colorcon Inc., Evonik Industries AG, among others. Market players are focusing on the financial support toward the research and development toward the technical advancements of the tablet coatings thereby supporting the global tablet coating market in the next five years.
Attribute | Details |
Base Year | 2022 |
Historical Years | 2018 – 2021 |
Estimated Year | 2023 |
Forecast Period | 2024 – 2028 |
Quantitative Units | Revenue in USD Million and CAGR for 2018-2022 and 2023-2028 |
Report Coverage | Revenue forecast, company share, competitive landscape, growth factors, and trends |
Segments Covered | Polymer Application Functionality Type End User |
Regional Scope | North America; Asia Pacific; Europe & CIS; South America; Middle East & Africa |
Country Scope | United States; Canada; Mexico; China; India; Japan; South Korea; Australia; Germany; France; United Kingdom; Spain; Italy; Brazil; Argentina; Colombia; Saudi Arabia; UAE; South Africa |
Key Companies Profiled | Air Liquide S.A., Sensient Technologies Corporation Ltd., Merck KGaA, Kerry Group PLC, DuPont De Numeours Inc., Aquadry Pharma Pvt. Ltd., BASF SE, Biogrund GmbH, Colorcon Inc., Evonik Industries AG. |
Customization Scope | 10% free report customization with purchase. Addition or alteration to country, regional & segment scope. |
Pricing and Purchase Options | Avail customized purchase options to meet your exact research needs. Explore purchase options |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |